Deng et al., suggested that the NLRP3 inflammasome activation stimulated by ROS generation, promoted the metastatic cascade in breast tumor cells59, while Xiong et al. proposed the anti-tumor role of inflammasome in immunogenic therapies60. Here, NLRP3 is linked to breast neoplasm.